Muhimbili University of Health and Allied Sciences is a public university in Dar es Salaam, Tanzania. It is accredited by the Tanzania Commission for Universities.

During the past decade, Muhimbili University of Health and Allied Sciences conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Muhimbili University of Health and Allied Sciences" #1 sponsor was "Harvard School of Public Health (HSPH)" with 7 trials, followed by "Muhimbili University of Health and Allied Sciences" with 5 trials sponsored, "Dartmouth-Hitchcock Medical Center" with 4 trials sponsored, "Medical University of South Carolina" with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Muhimbili University of Health and Allied Sciences" #1 collaborator was "Muhimbili University of Health and Allied Sciences" with 14 trials as a collaborator, "Karolinska Institutet" with 5 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator and "Boston Children's Hospital" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Muhimbili University of Health and Allied Sciences" are "HIV Infections" (6 trials), "HIV" (4 trials), "Tuberculosis" (3 trials), "Anemia" (2 trials) and "Diarrhea" (2 trials). Many other conditions were trialed in "Muhimbili University of Health and Allied Sciences" in a lesser frequency.

Most popular intervention types in "Muhimbili University of Health and Allied Sciences" are "Drug" (11 trials), "Behavioral" (9 trials), "Dietary Supplement" (7 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Zinc" (3 trials), "Vitamin A" (2 trials), "Adolescent Wellness Visit" (1 trials) and "Appreciative Inquiry Change Agents (CA) program (NAMWEZA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Muhimbili University of Health and Allied Sciences" are 24 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Muhimbili University of Health and Allied Sciences". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Muhimbili University of Health and Allied Sciences, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Muhimbili University of Health and Allied Sciences, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".